DUBLIN, December 9, 2022 /PRNewswire/ — Oncology Gene Therapy Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene-Induced Immunotherapy) and End User (Hospitals, Diagnostic Centers, Research Institutes) Report 2022-2027″ has been added to from ResearchAndMarkets.com offer.
The Oncology Gene Therapy Market Size has been valued at 2045 million US dollars in 2021 and is expected to grow at a compound annual growth rate (CAGR) by 23.7% over the 2022-2027 period. The Oncology Gene Therapy Market report provides executive-level insight into the global oncology gene therapy market today, with detailed forecasts of key indicators through 2027.
This market intelligence report offers in-depth and forward-looking analysis of the global oncology gene therapy market along with a stack of key products and platforms in a concise format to help executives build proactive growth strategies. and profitable.
Key to growth has been the high prevalence of cancer and increased investment and funding for product development. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate the growth of the market. During the forecast period, the market will witness an increase in government initiatives, supporting the growth of the oncology gene therapy market.
Scope
- This report provides an overview of the addressable gene therapy market in the oncology market
- It identifies key trends impacting market growth over the next 12 to 24 months, divided into three categories: technology trends, macroeconomic trends, and regulatory trends.
- It includes global market forecasts for gene therapy in oncology industry
- It includes industry forecasts and vendor overview on major vendors operating in or gene therapy in Oncology industry
Reasons to buy
- This market intelligence report offers in-depth, forward-looking analysis of the global oncology gene therapy market and key opportunities in a concise format to help executives develop proactive and profitable growth strategies.
- Accompanying the publisher’s Forecast products, the report examines the assumptions and drivers behind current and upcoming trends in gene therapy in oncology markets.
- The report also highlights major therapy types and end-user segments.
- With various charts and tables, the report is designed for an executive-level audience, providing quality presentation.
- The report provides an easily digestible market assessment for decision makers based on in-depth insights gathered from market players, which enables executives to quickly familiarize themselves with current and emerging gene therapy trends in the markets. oncology.
Main topics covered:
CHAPTER 01 Executive Summary
CHAPTER 02 Search scope and segmentation
CHAPTER 03 Technology briefing
CHAPTER 04 Oncology Gene Therapy Industry Trend Analysis
CHAPTER 05 Global revenue opportunity for gene therapy in oncology
CHAPTER 06 Regulatory Overview
CHAPTER 07 Gene therapy in oncology Type of therapy Perspectives
CHAPTER 08 Gene Therapy in Oncology End User Perspectives
CHAPTER 09 Gene Therapy in Oncology Regional Perspectives
CHAPTER 010 Trends, drivers and challenges
CHAPTER 011 Global Competitive Landscape of Gene Therapy in Oncology
CHAPTER 012 Appendix
Companies cited
- Amgen
- BMS
- Gilead (KitePharma, Inc.)
- Janssen Biotech, Inc.
- Novartis
- Shanghai Sunway Biotech
- Shenzhen Sibiono GeneTech
Source: Global Data
For more information about this report visit https://www.researchandmarkets.com/r/nyuim1
Media Contact:
Research and Markets
Laura Woodsenior
[email protected]
For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets